Navigation

Skiplink Navigation

Main Features

Markets disappointed with Synthes-Stratec numbers

The headquarters of Sythes-Stratec in Oberdorf

(Keystone Archive)

Shares in the medical technology company, Synthes-Stratec, fell by more than five per cent on Thursday as the markets expressed their disappointment with the company's latest figures.

Synthes-Stratec reported a 32 per cent increase in operating earnings on Thursday on sales growth of 26 per cent. The company said sales stood at SFr1.33 billion ($797 million) compared to SFr1.05 billion in 1999.

Net profit before extraordinary costs rose by 38 per cent to SFr298.3 million which was slightly below analysts' expectations. But after goodwill amortisation, the company had a loss of SFr39 million. This compared to SFr60.8 million in 1999.

Sales in bone repair rose 27 per cent to SFr1.27 billion. In prosthetics, sales rose 10 per cent to SFr65.1 million.

The company was formed in 1999 by the merger of the United States company, Synthes, and the Swiss company Stratec.

swissinfo with agencies


Links

Neuer Inhalt

Horizontal Line


subscription form

Form for signing up for free newsletter.

Sign up for our free newsletter and get the top stories delivered to your inbox.

swissinfo EN

The following content is sourced from external partners. We cannot guarantee that it is suitable for the visually or hearing impaired.

Join us on Facebook!

×